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p53 target prediction <p>Hidden Variable Dynamic Modelling is a new approach to microarray analysis that quantitatively predicts the regulation of gene activ- ity.</p>
Abstract
Full exploitation of microarray data requires hidden information that cannot be extracted using
current analysis methodologies. We present a new approach, hidden variable dynamic modeling
(HVDM), which derives the hidden profile of a transcription factor from time series microarray
data, and generates a ranked list of predicted targets. We applied HVDM to the p53 network,
validating predictions experimentally using small interfering RNA. HVDM can be applied in many
systems biology contexts to predict regulation of gene activity quantitatively.
Background
In order to understand how gene networks function, it is nec-
essary to identify their components and to quantitatively
describe how they relate to one another [1-3]. Subsequent
prediction of gene network behavior requires identification of
important parameters and variables, and estimation or meas-
urement of their values during a response [4-6].
Experimental approaches can be applied to identify network
components. For example, protein binding arrays and chro-
mosome immunoprecipitation can be applied to identify
transcription factor (TF)-binding sites and therefore infer TF
targets [7-10]. However, these approaches give a static view of
the system. Binding sites identified in vitro may not be avail-
able in vivo, and different regulators may be active in differ-
ent cellular systems. Furthermore, purely experimental
approaches cannot predict in a quantitative manner, and with
statistical confidence, the dynamics of network activity with-
out making an impractical number of experimental observa-
tions [11].
Insight into the dynamic relationships present in a transcrip-
t i o n a l  r e s p o n s e  c a n  b e  g a i n e d  b y  r u n n i n g  t i m e  s e r i e s  o f
microarrays [3,11,12]. Currently, analysis of this type of
datum chiefly relies on clustering or correlation methods. The
assumption is that groups of genes with similar expression
profiles over time are likely to be regulated by the same TF.
Although clustering approaches have been applied with some
success, they are limited and inaccurate. Genes with different
profiles may still be regulated by the same TF, and many
genes included in clusters may be regulated by other factors.
Clustering approaches typically do not generate confidence
statistics about the validity of individual predictions, and
therefore they can neither rank candidates nor distinguish
between true and false targets.
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Importantly, because clustering is based on only the expres-
sion time profile, the influence of other important factors
required to reconstruct gene network activity is not taken into
account. For example, transcript degradation rates, the sensi-
tivity of a gene to a TF (or affinity of binding to the promoter),
and the activity of the TF itself all contribute to the overall
transcriptional output. Where clustering methods alone are
applied, these quantities remain hidden in the data and are
likely to confound any attempted analysis. As a consequence,
microarray experiments typically return a list of targets based
on expression level alone, and prioritization of genes of inter-
est depends chiefly on researcher intuition.
An alternative strategy is to use a mathematical model of the
network dynamics to provide a framework for the analysis of
the expression time profile. Several types of model have been
applied at different levels of complexity ranging from parts
lists to dynamic models [3,11,12]. In theory, modeling can be
applied to reconstruct a gene network in a quantitative man-
ner [3,11,13]. The advantage of such an approach is that all of
the important mechanisms that affect transcript levels can be
taken into account simultaneously. Statistical confidence
intervals can then be calculated, which allow the prediction of
transcriptional targets with a specified statistical significance.
As a result it is possible to predict how network regulation
would change in response to differing conditions, allowing
the optimal targeting of expensive experimental approaches.
We therefore developed a mathematical approach that uses
information from a dynamic microarray time series data set
to estimate, with confidence intervals, key parameters and
hidden variables, specifically TF activity profiles. We define
TF activity in terms of the positive effect that the TF has on
transcription of its targets. We chose as a model experimental
system the transcriptional response to ionizing irradiation.
Ionizing radiation induces DNA damage, which in turn acti-
vates the p53 response [14]. p53 is a transcription factor and
tumor suppressor, but it is only one of several TFs activated
by DNA damage [15,16].
Our analysis method allows quantitative prediction, with con-
fidence, of transcripts that are upregulated by p53 in the com-
plex response, without the need for very large numbers of
experimental observations. We have made use of prior bio-
logic information (known p53 targets) to construct a mathe-
matical model of gene regulation, calculated confidence
intervals using a highly efficient novel approach, and
anchored the model by including a surprisingly small amount
of additional biologic information. We show that the model
outperforms a clustering approach in terms of accuracy of tar-
get prediction, and we successfully tested model predictions
with a separate experimental data set.
Results
A model of transcription factor-dependent gene 
transcription
We grew and irradiated a human leukemia cell line (MOLT4)
containing functional p53 and harvested protein and RNA at
regular intervals after irradiation. The time course was per-
Model based estimation of activity profile of p53 Figure 1
Model based estimation of activity profile of p53. (a) Markov Chain Monte 
Carlo output for potential transcription factor activity profile values for 
first time series replicate at 4 hours (x axis) and 6 hours (y axis). (b) 
Concentration of p21WAF1 transcript determined by real-time polymerase 
chain reaction after addition of actinomycin D (10 µg/ml) to irradiated (5 
Gy, 4 hours) MOLT4 cells cultured in RPMI. Expressed as percentage of 
initial concentration. (c) Using the degradation rate of p21WAF1 
dramatically restricted the range of solutions to the Markov Chain Monte 
Carlo.
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formed in triplicate, and Affymetrix U133A microarrays
(Affymetrix Inc., Santa Clara, CA, USA) were run to measure
the global transcriptional response. Before irradiation, we
assumed the p53 network to be in equilibrium (that is, that
the rate of change in its constituents is zero). Irradiating the
cells disrupts the equilibrium and activates transcription of
numerous p53 target genes. The rate at which p53-dependent
mRNA transcripts accumulate depends on the basal tran-
scription rate of a target gene, the sensitivity of the gene to
p53, the level of activity of p53, and the transcript degradation
rate. We can connect these factors to represent the overall
behavior of the system. The time evolution of each gene tran-
script is described by the following non-autonomous linear
differential equation for the rate of change in transcript con-
centration xj(t) of gene j at time t:
Where Bj is the constant basal transcription rate of j; Sjf(t) is
the transcription induced by p53, composed of a constant Sj,
which is the sensitivity of gene j to p53, and f(t), which is the
activity of p53 at time t; and Djxj(t) is a degradation term, with
Dj being a constant degradation rate. For a full description of
the model, see Mathematical methodology (below).
Parameter estimation for a training set of five known p53 targets Figure 2
Parameter estimation for a training set of five known p53 targets. (a) The model equation was solved to estimate values for the parameters basal 
transcription Bj sensitivity Sj, and degradation Dj for the five p53 targets DDB2, p21WAF1/CIP1, SESN1/hPA26, BIK, and TNFRSF10b/TRAILreceptor 2. (b) 
Simultaneously, the activity profile f(t) of p53 was derived from three separate microarray time courses.
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Deriving the hidden activity profile of p53
In order to predict whether a gene is likely to be a p53 target,
it is necessary to estimate its sensitivity (Sj) to p53 and to
ensure that parameter values can be found that, when com-
bined in the model equation, result in an expression profile
similar to the experimentally determined profile. However,
the p53 activity f(t) is not experimentally available and is the
key 'hidden variable' in the system. To estimate this profile we
used prior biologic knowledge rather than adopting a 'black
box' approach. We selected a small training set of five known
p53 targets (DDB2,  p21WAF1/CIP1,  SESN1/hPA26,  BIK, and
TNFRSF10b/TRAILreceptor 2) [17-22] and used the micro-
array time series observations for this set to derive the p53
activity profile f(t), and the parameter values of basal tran-
scription rate, sensitivity to p53, and degradation rate. These
values and their confidence intervals were obtained by apply-
ing Markov Chain Monte Carlo (MCMC) with a Metropolis-
Gibbs sampler [23] (see Mathematical methodology, below).
Normally, the calculations involved in these estimations are
very demanding on computer time. In terms of systems biol-
ogy, in which many such calculations are likely to be linked,
this poses a major barrier to network analysis. We therefore
discretized the model equation and devised a fast matrix-
based algorithm to solve it efficiently (see Mathematical
methodology, below).
Initial estimates of the parameters and the hidden profile f(t)
exhibited a very high degree of variance. Repeated modeling
of artificial data indicated that this was a general characteris-
tic of the model and not peculiar to the particular experimen-
tal data set. We noticed that the estimates were highly
correlated with each other (Figure 1a). This suggested that
experimentally determining the value of one additional
parameter might constrain the others and so reduce the over-
all variance. We therefore measured the rate of degradation of
one transcript (p21WAF1/CIP1) using quantitative polymerase
chain reaction (PCR; Figure 1b). We found that this single
measurement was sufficient to reduce dramatically the vari-
ance and greatly improve the final estimates (Figure 1c). We
term this process 'data anchoring'. We found that obtaining
the degradation rate of any element in the training set was
equally sufficient to anchor the model, provided that the same
gene was also used as the reference point for estimating sen-
sitivity (see Mathematical methodology, below). The inclu-
Experimentally determined p53 activity profile Figure 3
Experimentally determined p53 activity profile. The activity profile of p53 
was measured by Western blot to determine the levels of ser-15 
phosphorylated p53 (ser15P-p53). ser-15 phosphorylation is a measure of 
p53 activity. IR, ionizing radiation. IR, ionizing irradiation.
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Choice and number of training set genes does not significantly affect the  predicted activity profile Figure 4
Choice and number of training set genes does not significantly affect the 
predicted activity profile. (a) Predicted activity profile of p53 derived using 
different numbers of known targets in the training set, from three to ten 
genes. (b) Predicted activity profile of p53 derived using 100 combinations 
of three randomly selected training set genes from a pool of 10 known 
targets.
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sion of the degradation rates of more genes did not
significantly improve parameter estimation.
Incorporation of the degradation data allowed efficient esti-
mation of the parameters Bj, Sj and Dj, and the p53 activity
profile f(t) for the training set of known targets (Figure 2).
This process was performed simultaneously on three repli-
cate time series to improve the robustness of the outcome
( F i g u r e  2 b ) .  W e  f o u n d  t h a t  the model-estimated profile
approximated the experimentally determined activity profile
based on measuring p53 phosphorylation at serine 15 [24]
(Figure 3). The profiles show a close match early in the
response, but the model predicts a more rapid decline in
activity. This discrepancy can be explained by the operation of
other regulatory mechanisms that affect p53 activity but not
concentration, for example relocation of phosphorylated p53
to the cytoplasm [25].
Hidden variable dynamic modeling screening of upregulated genes Figure 5
Hidden variable dynamic modeling screening of upregulated genes. Model predicted profile (red) and experimental expression profile (black) of typical 
genes representing two classes of model prediction (class 1 and class 2). (a) Class 1 genes with good model score (M < 100) and high sensitivity P value 
(sensitivity Z score > 2; for example LRMP). (b) Class 1 genes with atypical expression profiles (for example, p53TG1); this profile occurs because of a low 
predicted degradation rate. (c,d) Two class 2 genes with low model score (M > 100) but high sensitivity P value (sensitivity Z score > 2; for example, 
TNFSF10 and IER3).
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Table 1
Top 50 genes predicted by hidden variable dynamic modeling to be p53 regulated, ranked by sensitivity Z score
Gene title Gene symbol Affymetrix identifier Model score (M) Sensitivity (Z score) RNAi validation score
Damage-specific DNA binding protein 
2, 48 kDa
DDB2 203409_at 18.74 18.24 10.74
CD38 antigen (p45) CD38 205692_s_at 36.69 14.77 9.02
Ferredoxin reductase FDXR 207813_s_at 79.82 13.19 7.72
Hypothetical protein FLJ22457 FLJ22457 221081_s_at 60.45 11.01 6.33
Tripartite motif-containing 22 TRIM22 213293_s_at 41.36 10.99 6.07
Carnitine O-octanoyltransferase CROT 204573_at 84.40 10.98 3.80
Glutaminase 2 (liver, mitochondrial) GLS2 205531_s_at 42.83 10.28 2.52
Leucine-rich repeats and death 
domain containing
LRDD 219019_at 78.80 9.90 3.09
Hect domain and RLD 5 HERC5 219863_at 37.65 9.55 1.91
Cyclin G1 CCNG1 208796_s_at 17.04 9.37 5.18
BCL2-interacting killer BIK 205780_at 19.43 9.35 6.57
Activating signal cointegrator 1 complex 
subunit 3
ASCC3 212815_at 60.34 9.26 5.93
Sestrin 1 SESN1 218346_s_at 8.37 9.25 3.90
p53 target zinc finger protein WIG1 219628_at 41.33 9.19 3.70
Tumor necrosis factor receptor 
superfamily, member 10b
TNFRSF10B 209295_at 27.34 9.05 6.52
Chromosome 6 open reading frame 4 C6orf4 215411_s_at 86.45 8.81 6.64
Cyclin-dependent kinase inhibitor 
1A(p21)
CDKN1A 202284_s_at 24.98 8.40 8.07
Etoposide induced 2.4 mRNA EI24/PIG8 216396_s_at 88.04 8.20 4.09
Mitogen-activated protein kinase kinase kinase 
kinase 4
MAP4K4 206571_s_at 62.88 7.54 1.88
Lymphoid-restricted membrane protein LRMP 204674_at 26.92 7.36 3.40
Xeroderma pigmentosum, group C XPC 209375_at 43.09 7.36 5.80
TNF (ligand) superfamily, member 4 
(Ox40L)
TNFSF4 207426_s_at 34.73 7.15 5.26
Human cleavage/polyadenylation 
specificity factor
CPSF1 33132_at 77.75 7.09 -1.44
AMP-activated protein kinase, beta 1 
subunit
PRKAB1 201834_at 25.72 7.01 6.30
Transducer of ERBB2, 1 TOB1 202704_at 92.69 6.79 5.78
p53-inducible cell-survival factor P53CSV 218403_at 48.33 6.50 7.75
Sortilin-related receptor, L(DLR class) SORL1 203509_at 15.66 6.34 1.70
Fas (TNF receptor superfamily, 
member 6)
FAS 216252_x_at 44.31 6.23 4.54
Ribonucleotide reductase M1 
polypeptide
RRM1 201477_s_at 46.58 6.19 0.41
Archaemetzincins-2 AMZ2 218167_at 37.48 6.16 1.22
Galactose-3-O-sulfotransferase 4 GAL3ST4 219815_at 38.62 5.97 3.12
Growth arrest and DNA-damage-
inducible, alpha
GADD45A 203725_at 84.23 5.89 11.05
Hypothetical protein FLJ11259 FLJ11259 218627_at 7.23 5.87 3.56
Major histocompatibility complex, class I, B HLA-B 209140_x_at 89.77 5.79 0.63
Testis specific, 10 TSGA10 220623_s_at 20.85 5.67 0.47
Hypothetical protein MDS025 MDS025 218288_s_at 31.35 5.66 2.38
TP53 activated protein 1 TP53AP1 209917_s_at 22.22 5.65 4.05
Leukemia inhibitory factor LIF 205266_at 14.86 5.62 3.42
Interferon stimulated exonuclease gene 20 
kDa-like 1
ISG20L1 219361_s_at 48.55 5.56 5.43http://genomebiology.com/2006/7/3/R25 Genome Biology 2006,     Volume 7, Issue 3, Article R25       Barenco et al. R25.7
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Optimization of the model
The use of a training set of known targets takes advantage of
the fact that prior biologic knowledge exists for many TFs.
Because the p53 response is well studied, we were able to
examine the optimum model requirements. We found that
three training genes are sufficient for the model to make accu-
rate parameter estimates (Figure 4a). The inclusion of more
(up to ten) genes narrowed the confidence intervals but the
improvement was small beyond five genes. We also found
that inclusion of genes not regulated by p53 (for example
TNFSF10) led to a poor gene-specific model score, enabling
these genes to be excluded from the training set. We found the
method to be very robust, and the exact choice of target genes
does not appear to affect estimation greatly, providing that
the measurement error is not excessive (namely, the detec-
tion P value should be below 0.001 for Affymetrix data) and
that the anchoring gene is clearly differentially regulated
(Figure 4b; also see Mathematical methodology, below).
Prediction of p53 targets using hidden variable 
dynamic modeling
Once we had constructed the estimate for the key 'hidden var-
iable', namely the p53 activity profile f(t), we were able to
apply the model to the remaining expression data to predict
p53 targets. Data was filtered to identify upregulated and
detected genes (754 in total). These were then tested to deter-
mine how well they fitted the model of activation by p53. We
derived a score M (> 0) based on the closeness of experimen-
tal data to model predictions (in which lower scores are bet-
ter). Because nonchanging genes with a flat profile would also
fit the model, another score was computed that captures the
predicted sensitivity to p53. This sensitivity score is a meas-
ure of how significantly Sj differs from zero, represented by a
Z score. Z scores are the distance between the observed value
and the population mean in units of standard deviation, and
are therefore a measure of estimation robustness. Z scores are
inversely related to P  values (see Materials and methods,
below).
We ranked the model scores, first in terms of model fit and
then on predicted sensitivity to p53. Three broad classes of
upregulated genes could be discerned, the composition of
which depending on the stringency of the M score and sensi-
tivity Z score threshold applied. At thresholds of M < 100 and
sensitivity Z > 2 (and degradation estimates limited to 0.1/
hour < Dj < 5/hour), class 1 consisted of 237 genes that fitted
the model well and exhibited high probability of p53 sensitiv-
ity, exemplified by LRMP and p53TG1 (Figure 5a,b). Class 1
genes were therefore most likely to include genes regulated by
p53, with the probability of sensitivity being the key indicator.
As expected, the five known targets composing the training
set were found among the 20 highest scoring genes (ranked
by decreasing sensitivity Z score), alongside other established
p53 targets and genes not previously known to be p53 regu-
lated (Table 1).
Under the same thresholds, in a second class of 105 genes a
relatively high sensitivity score was achieved despite a poor
model fit, as in the case of TNFSF10 (TRAIL) and IER3 (Fig-
ure 5c,d). The model attempts to accommodate genes
strongly regulated by factors other than p53 by varying degra-
dation and sensitivity scores, which often results in appar-
ently high sensitivity predictions. However, the poor overall
model fit suggests that class 2 genes are either completely
independent of p53 or exhibit more complex co-regulation.
Genes in class 3 have either poor sensitivity or poor model
score (M > 100, sensitivity Z < 2), or both. The majority of the
412 genes in this group are likely to be regulated independ-
ently from p53 in a manner that exhibits no similarity to the
p53 activity profile. However, class 3 will also include genes
Lymphoid-restricted membrane protein LRMP 35974_at 42.06 5.56 3.69
Integral membrane protein 2B ITM2B 217732_s_at 20.25 5.52 -0.19
Tumor necrosis factor receptor 
superfamily, member 10b
TNFRSF10B 210405_x_at 46.05 5.52 1.69
REV3-like, catalytic subunit DNA 
polymerase zeta
REV3L 208070_s_at 65.17 5.45 6.73
TP53 activated protein 1 TP53AP1 210886_x_at 30.15 5.42 2.88
Leucine-rich repeats and death 
domain containing
LRDD 221640_s_at 55.27 5.31 1.54
AMP-activated protein kinase, beta 1 PRKAB1 201835_s_at 25.45 5.27 5.92
Nonmetastatic cells 1 (NM23A) NME1 201577_at 83.39 5.15 3.38
Tubulin, gamma 1 TUBG1 201714_at 41.74 5.09 0.02
Solute carrier family 7, member 6 SLC7A6 203579_s_at 18.59 4.98 2.56
RAD51 homolog RAD51C 209849_s_at 21.02 4.92 1.11
Low model scores and higher Z score constitute better model fits. The data are compared with validation scores for gene sensitivity to small 
interfering (si)RNAp53 (higher = better). Plain text indicates genes not previously recorded as p53 targets. Bold text indicates experimentally 
demonstrated p53 targets.
Table 1 (Continued)
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Figure 6 (see legend on next page)
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that are p53 dependent but that are not distinguishable by the
model.
Verification of model predictions using small 
interfering RNA to p53
To validate the predictions made by the model, we transfected
MOLT4 cells with small interfering (si)RNA to p53 to deplete
p53 protein to below control levels (Figure 6a) [26].
siRNAp53 substantially reduced ionizing irradiation-induced
increases in the transcripts of three p53 target genes, namely
HDM2, P21, and GADD45α (Figure 6b). We then ran micro-
arrays to measure the effect of siRNAp53 on the transcrip-
tional response to irradiation at the whole genome level.
Validation was carried out at 4 hours to maximize the number
of p53 targets and to minimize the inclusion of secondary tar-
gets. Data were filtered to identify those genes that were
upregulated in both the time course and in the pSuper
transfected control at 4 hours (see Materials and methods,
below). This identified a total of 162 genes that were upregu-
lated significantly by irradiation at 4 hours.
To quantify sensitivity to siRNAp53 at the individual gene
level, we computed new Z scores that measured the difference
between genes upregulated by irradiation in control cells and
those upregulated in siRNAp53 treated cells. For clarity,
these are referred to as validation scores. The higher the vali-
dation score, the more effectively siRNAp53 eliminates
change in transcript concentration, and so the more likely the
gene is to be dependent on p53. Seventy-four of the 162 4-
hour-upregulated genes were predicted by the model to be
p53 targets because they fell into class 1 (M < 100 and sensi-
tivity Z score > 2). Of these 74, 66 (90%) exhibited high (Z >
1) validation scores (namely sensitivity to siRNAp53), con-
firming that they are p53 targets (Figure 7a). This figure rises
to 73 out of 74 (98%) if a lower sensitivity Z score threshold (>
0.5) is applied or falls to 39 out of 74 (53%) if the sensitivity Z
score threshold is set at 3. Higher sensitivity Z score thresh-
olds therefore result in greater accuracy but at the expense of
identifying a lower proportion of the targets (Figure 7b). Sen-
sitivity Z score correlated well with validation score, indicat-
ing that predicted rank of p53 targets reflected the strength of
p53 regulation (Figure 7c).
Thirty upregulated (4 hours) genes fell into class 2 (M > 100
and sensitivity Z score > 2). As expected, the response of class
2 genes to siRNAp53 was divided. Fourteen genes, including
TNFSF10  (TRAIL), remained unaffected by siRNAp53,
showing them to be p53 independent/irradiation dependent.
Sixteen class 2 genes were affected to some degree by the
treatment, confirming predictions that this group included
co-activated or co-repressed genes such as IER3, which is
known to be synergistically regulated by nuclear factor-κB
and p53 [27]. The remaining 58 upregulated (4 hours) genes
fell into class 3, 34 of which were affected by siRNAp53.
Overall the Z score for Sj (sensitivity to p53) was a good dis-
criminator for identifying p53 targets. The model was able to
predict with confidence, and at high accuracy, 66 out of 115
(57%) genes verified as p53 targets at 4 hours, based on a sen-
sitivity Z score threshold of 2. A further 16 class 2 genes exhib-
ited evidence of co-regulation, suggesting an explanation for
71% of the interpretable data. Many of the remaining class 3
targets were expressed at low levels, or exhibited low (> 1.5-
fold) levels of differential expression. This raises questions
about their biologic significance, and suggests that the true
success rate of hidden variable dynamic modeling (HVDM) is
actually higher than reported above. A larger number of rep-
licates would be required to be confident of the status of class
3 genes.
As seen for the validation data set, tightening thresholds (by
choosing a higher sensitivity Z score) results in more confi-
dence that the targets are regulated by p53 but at the cost of
explaining a lower percentage of the data (Figure 7). When
applied to the entire upregulated data set, HVDM can accu-
rately predict a large number of p53 targets from a short time
course without any further experimental input (Figure 8).
These predictions included a number of genes not previously
known to be p53 targets, including CD38, DENN-domain
protein FLJ22457, CROT, GLS2, HERC5, ASCC3, LRMP, and
Small interfering (si)RNAp53 reduces p53 protein levels and transcription of p53 target genes Figure 6 (see previous page)
Small interfering (si)RNAp53 reduces p53 protein levels and transcription of p53 target genes. (a) Transfection of siRNAp53 reduces p53 protein levels 
below control values. (b) Real-time quantitative polymerase chain reaction measurement of three p53 target genes (GADD45α, p21, and HDM2) and a 
control gene (GAPDH) after transfection of siRNAp53 and irradiation. IR, ionizing irradiation.
Model validation Figure 7 (see following page)
Model validation. (a) Effect of small interfering (si)RNAp53 on irradiation (5 Gy) induced change in transcript levels at 4 hours of the 74 class 1 genes. (b) 
Effect of altering Sj Z score threshold for class 1 on proportion of true targets identified (% of p53 upregulated genes at 4 hours predicted; black line) and 
accuracy of class 1 predictions (percentage of predictions made that were verified by siRNAp53; red line). Accuracy and proportion of the data explained 
reveal an inverse relationship. (c) Individual comparison of the effect of siRNAp53 on 74 class 1 genes with the best M and p53 sensitivity Sj score, ranked 
by sensitivity. Bars represent the validation score, a Z score measuring the effectiveness of siRNAp53 on reducing post-irradiation upregulation of 
transcript. Higher scores indicate effective blocking of the response.R25.10 Genome Biology 2006,     Volume 7, Issue 3, Article R25       Barenco et al. http://genomebiology.com/2006/7/3/R25
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Figure 7 (see legend on previous page)
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CIKS/ACT1/TRAF3IP2  (Table 1). siRNA validation at an
early time point (4 hours) indicates that these genes are most
likely to be direct targets. CD38 is best known as a prognostic
marker in the leukemia B cell lymphocytic leukemia (B-CLL
associated) with poor outcome. It functions as a powerful reg-
ulator of calcium dependent signaling via the generation of
cyclic ADP ribose and NAADP+ (nicotinic acid adenine dinu-
cleotide phosphate) Its regulation by p53 suggests a possible
role for calcium-dependent signaling in the DNA damage
response.
Hidden variable dynamic modeling predicts p53 
targets more accurately than does K means clustering
Since both HVDM and clustering approaches aim to identify
TF targets, we compared our results with a typical clustering
approach, namely K means clustering. From the 754 genes
identified as upregulated by irradiation, HVDM generated a
ranked list of predicted p53 targets based on model score and
best sensitivity Z scores (Table 1). Forty-eight of the 50 high-
est ranked targets (96%) predicted by HVDM were confirmed
by siRNA to be p53 targets. These 50 HVDM predicted target
genes were divided by K means clustering between six of eight
clusters, each with a distinct response profile (Figure 9). For
example, the HVDM predicted target TP53TG1  has a late
expression profile (cluster 1, Figure 9), along with seven other
top 50 targets. This profile is quite different from the activa-
tion profile of p53 or its 'typical' correlated targets (Figure
5b). Only two genes were probably false positives.
K means clustering of the 754 detected and upregulated genes
based on expression levels alone grouped the genes into eight
clusters based on transcript time profile (Figure 9). Visual
examination of the profiles suggested that one of these classes
(cluster 7, Figure 9) was most similar to the p53 activity pro-
file determined by Western blot (Figure 5b), and indeed this
cluster contained many of the well known p53 targets (includ-
ing GADD45α, p21, and DDB2). However, because clustering
approaches typically do not provide confidence intervals, it is
impossible to identify which genes within the cluster are most
or least likely to be real targets. We found that 25 out of 79
genes in cluster 7 were verified as p53 targets in the siRNA
experiment (32%; data not shown). Verified genes also
occurred in cluster 1 (11 out of 135 (8%)), cluster 3 (35 out of
102 (34%)), cluster 4 (21 out of 120 (17.5%)), cluster 5 (3 out
of 90 (3.3%)), and cluster 6 (20 out of 51 (39%)).
In summary, HVDM can generate an accurate list of p53 tar-
gets with different expression profiles, ranked by probability
of sensitivity to p53. In contrast, although K means clustering
generates clusters enriched or depleted in p53 targets, it fails
to identify targets with different profiles, is unable to quantify
the level of sensitivity of a gene to p53, and cannot distinguish
between true and false p53 targets. We also assessed the per-
formance of self-organizing maps (SOM) clustering, with a
similar outcome. This is expected, given that all processes
that cluster on expression profile alone are bound to suffer
similar deficiencies. Predictions made by HVDM are there-
fore accurate, explain a significant proportion of true targets,
give indications about potential for co-regulation, and
provide an excellent basis for prioritization of downstream
bioinformatics and experimental analysis.
Discussion
We present here an approach based on a simple differential
equation model that uses hidden information to partially
reconstruct, with confidence intervals, the p53 target net-
work. Our algorithm, which we term hidden variable dynamic
modeling, operates on two levels. First, it offers a quantitative
d e s c r i p t i o n  o f  a  T F  o u t p u t  network at the genomic level.
Second, it provides a practical resource to enable the predic-
tion of targets and a probability based prioritization of array
data for downstream analysis.
Mathematical modeling of gene networks has taken a variety
of approaches [3,11,12]. At the genome level, topographic
network reconstruction has been achieved using a variety of
methods and data sources, including microarray data [1,28-
30]. In contrast, dynamic modeling has typically been limited
to short pathways or feedback loops because of the complex-
ity associated with estimating high dimensional models [11].
Some attempts to group network behavior into modules for
dynamic modeling have been successful [13]. Others have
attempted dynamic modeling of whole microarray data sets
using differential equation models to derive transcriptional
profiles [5,6,31]. However, these interesting studies stop
short of calculating confidence intervals that take into
account measurement error and variability [31,32]. Without
these measurements, the reliability of the model cannot be
Model performance Figure 8
Model performance. Distribution of 459 upregulated genes that pass 
degradation filter based on model score and predicted sensitivity to p53. Sj 
Z score = 3 and model = 100 thresholds are shown. A total of 115 Genes 
verified as p53 targets at 4 hours are shown in red.
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K means clustering of upregulated genes based on expression values Figure 9
K means clustering of upregulated genes based on expression values. A total of 754 upregulated genes were optimally grouped into eight K means clusters 
(C1 to C8). The 50 best hidden variable dynamic modeling predictions (Table 1) are split among six clusters (highlighted in yellow). Accurate prediction of 
p53 targets is therefore not possible using K means at this level.
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assessed. Neither do they test predictions made by the model
by experimentation.
Most microarray data are analyzed by subjecting them to var-
ious levels of statistical filtering to identify differences
between two or more conditions. The resultant list of genes
may then be segregated according to gene ontology using var-
ious tools designed for this purpose [33]. It is assumed that
co-regulation of genes with a particular ontology is of interest,
but this may be misleading and certainly cannot predict tar-
gets of a particular TF. Correlation approaches that cluster
genes that exhibit a similar time course expression profile are
more successful [34], but they are often inaccurate and miss
many genuine targets with a different profile. The advantage
of our approach is that it can predict genes with any profile as
targets of the same TF.
Complex data sets contain hidden information about gene
regulatory networks [35]. It has also been suggested that the
use of prior biologic knowledge can improve the reconstruc-
tion of genetic networks [36]. In generating our model, we
used a small amount of knowledge about TF targets to derive
the activity profile of p53 and then applied this to partially
reconstruct the p53 target network. Our model makes the
assumption that, given a short time course, much of the net-
work behavior can be explained using linear modeling, and
our verification experiment strongly supports this assertion
(Table 1). However, it is likely that some genes respond to p53
in a nonlinear manner, for instance as a result of saturation
and/or threshold effects. Future extensions of our model to
include these terms may explain an even higher proportion of
the behavior (work in progress). It should also be noted that
the model would be unable to distinguish between TFs with
identical activity profiles. Combination of HVDM with exper-
imental approaches or other in silico methods such as the
identification of TF-binding sites could help to resolve this
issue [37-39]. The current model is only able to account for
direct effects of the controlling TF, which is reasonable for the
short time course employed in our studies. Future modifica-
tions to the model will permit modeling of secondary effects,
namely genes upregulated at late time points that may be tar-
gets of targets.
HVDM correctly predicted the majority of p53 targets, includ-
ing all of the well known examples, directly from time series
measurements of a complex response. HVDM was also able to
identify, with associated probability, genes that had not pre-
viously been identified as p53 targets. Several previous
studies have aimed to identify p53 target genes on a genome
wide level using microarrays. Zhao and coworkers [22] iden-
tified p53 targets by using a Zn2+-inducible p53 construct
containing a metallothionein promoter. In this case, the spe-
cific induction of p53 required the establishment of a complex
and artificial in vivo system. p53 targets could not be directly
extracted from ionizing irradiation or ultraviolet irradiation
experiments alone. Also, targets induced in the artificial sys-
tem differed significantly from those induced by ionizing irra-
diation or ultraviolet, indicating that simple artificial systems
cannot replicate the behavior of complex activities during a
physiologic response. In another approach, Kannan and cow-
orkers [40] employed a temperature sensitive p53 to identify
p53 dependent transcription and used cycloheximide to dis-
tinguish between primary and secondary targets. However,
again, a complex artificial system was required. Furthermore,
temperature and cycloheximide are both likely to affect the
resultant transcription patterns, and because the data cannot
be ranked the reliability of many targets would require
additional experimental verification. HVDM has the advan-
tage that ranked probability based target lists can be
extracted from complex data without having to isolate each
factor experimentally.
We observed that genes that were affected by siRNAp53 but
not predicted by the model typically exhibited expression lev-
els close to the detection threshold or low levels of differential
regulation, or were poorly hybridizing alternative probe sets
for genes already predicted by the model to be targets. The
biologic significance of many apparent targets not identified
by the model is therefore questionable. The ability to provide
ranked lists of predicted (class 1) targets with a high degree of
confidence, and based on the minimum of input data, will
allow researchers to make optimal use of their resources.
Such prioritization has been lacking in microarray data anal-
ysis and has hampered the efficient interpretation of array
experiments.
It is important to note that the model is dynamic. It not only
identifies targets but also predicts network behavior in
response to changing conditions or altered parameters. For
example, treatment with a drug that alters p53 activity could
potentially be modeled entirely in silico based on its effects on
expression of the training set of target genes. This may have
implications for predicting the consequence of clinical or
experimental treatments [41].
Conclusion
We addressed the problem of extracting hidden information
from time series microarray data. We present a method that
models the p53 target network following DNA damage, in
which we use prior biologic information (a training set) to
construct a mathematical model of the transcriptional
response to DNA damage in MOLT4 cells. We have also
developed a method to calculate confidence intervals for
parameter estimates in a highly efficient manner. We found
that the inclusion of a surprisingly small amount of additional
biologic information was necessary to anchor the model.
Most importantly, we then successfully tested the model pre-
dictions with an entirely separate experimental data set.
Our model accurately predicted a significant proportion of
transcriptional targets of p53 and explained their behavior.R25.14 Genome Biology 2006,     Volume 7, Issue 3, Article R25       Barenco et al. http://genomebiology.com/2006/7/3/R25
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The model identified genes not previously known to be p53
regulated, and it is more widely applicable and more accurate
than correlation or clustering methods because it considers
degradation rates as well as transcript accumulation profiles.
Furthermore, HVDM can extract hidden information from
small data sets in which experimental methods would require
an impractical number of observations. Finally, HVDM
allows the probability-based prioritization of microarray
data, permitting researchers to exclude irrelevant informa-
tion and rapidly focus on the networks of interest.
HVDM can be applied to any large time series data set in
which identification of hidden variables can reveal critical
information about network dynamics. The approach is quan-
titative and predictive, and demonstrates that combining
mathematical modeling with experimental observations can
help to unravel complex relationships in biologic systems.
Materials and methods
Biological methods
Cell lines and reagents
Human MOLT4 cells (T cell acute lymphoblastic leukaemia)
were obtained from the National Institute for Biological
Standards and Controls (Potters Bar, Herts, K; CFARP011)
and cultured in RPMI, 10% fetal calf serum and L-glutamine,
plus antibiotics. p53 genotype was determined by sequencing
to verify wild-type status. p53 accumulation was monitored
after irradiation by quantitative Western blotting, and regula-
tion of known p53 targets (p21, GADD45α, and MDM2) fol-
lowing p53 activation by ionizing radiation was established to
confirm p53 wild-type behavior (data not shown). Western
blots were probed against total p53 (Santa Cruz Biotechnol-
ogy Inc. Santa Cruz, CA, USA), phospho-p53 (Cell Signalling
Technologies, Danvers, MA, USA), and actin (Santa Cruz).
Proteins were detected using enhanced chemiluminescence
(ECL+; GE Healthcare, Chalfont St Giles, Bucks, UK) and
quantified by densitometry.
Microarray time course
Cells in log phase (1 × 106/ml) were γ-irradiated with 5 Gy at
room temperature at a dose rate of 2.45 Gy/minute with a
137Cs γ-irradiator. Cells were harvested at 0, 2, 4, 6, 8, 10 and
12 hours, and RNA and protein were extracted (Trizol; Invit-
rogen, Paisley, UK). RNA and cRNA quantity and quality
were determined by Nanodrop spectophotometer and Bioan-
alyser 2100 (Agilent, Wokingham, Berks, UK). Affymetrix
U133A arrays (Affymetrix, Sanat Clara, CA, USA) were
hybridized as standard. Array quality was determined using R
and GCOS .rpt file values. The time course was replicated
three times from independent cell preparations.
Microarray data analysis
Microarray data were summarized using the MAS5.0 algo-
rithm (Affymetrix). Signal distribution was assessed using
Genespring 6.1 (Agilent), and data were normalised to the
median and log transformed for further analysis. For mode-
ling applications, rescaled MAS5.0 data were analyzed using
C code [42] (see Mathematical methodology, below). Data are
available in MAGE-ML format via ArrayExpress (European
Bioinformatics Institute) or on request.
Prediction of p53 targets
Data were filtered to identify 754 genes that were confidently
upregulated by ionizing radiation (but not necessarily by p53)
in at least one time point, and to exclude control genes (for
example, spike ins). We excluded genes predicted to have a
biologically impossible degradation rate (either close to zero
(< 0.01/hour) or with too short a half-life (rate > 5/hour)).
Next, we calculated the sum M of weighted differences
between the model predicted profile and the experimentally
determined transcript profile. Finally, the confidence that the
transcript was sensitive to p53 activation was assessed by
determining the probability that each individual sensitivity Sj
was equal to 0. The modeling and statistical techniques used
to compute these indicators are described extensively below.
Real-time quantitative polymerase chain reaction
MOLT4 cells were irradiated with 5 Gy and incubated at 37°C
for various time periods. First strand cDNA was prepared
(Invitrogen) and used as a template in PCR reactions with
predeveloped target assays (Applied Biosystems, Foster City,
CA, USA): p21, HDM2, GADD45, and GAPDH. Target and
reference were amplified in separate wells in a 96-well setup
with three replicates for each reaction on ABI Prism SDS
7000 (Applied Biosystems), using default cycling conditions.
Change in gene expression was calculated using 2-dCT, where
dCT  i s  t h e  m e a n  o f  C T  (threshold cycle number) values
obtained from the triplicate samples at each time point.
Small interfering RNA experiments
Cells were transfected with siRNAp53 (DNAEngine, Oligoen-
gine, Seattle, WA, USA) or the vector-only control (pSuper,
Oligoengine), together with a marker plasmid (pcDNAneo-
GFP) using electroporation. GFP-positive cells (40-50%)
were sorted 24 hours after transfection on a Mo-Flo FACS
sorter (Cytomation, Fort Collins, CO, USA) to a purity in
excess of 98%. Forty-eight hours later sorted cells were irra-
diated with 5 Gy or mock irradiated and incubated for 4 hours
at 37°C. RNA and protein were then prepared and processed
for real-time quantitiative PCR, protein analysis, and micro-
array. For verification, data was filtered to include genes
detected (Affymetrix P < 0.04 at t = 4 hours) and changed (Z
score > 1) at 4 hours in both the time course and in the pSuper
c o n t r o l ,  a n d  t o  r e m o v e  g e n e s  w h o s e  s i R N A p 5 3  c a l l  w a s
caused mainly by differences in basal transcription levels
(removing 28 out of 190 genes).http://genomebiology.com/2006/7/3/R25 Genome Biology 2006,     Volume 7, Issue 3, Article R25       Barenco et al. R25.15
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Mathematical methods
Model formulation
We assume that the transcript concentration xj(t) of gene j
satisfies the following time-dependent linear differential
equation:
This assumes that the transcript is degraded proportionally to
its concentration, with the degradation rate Dj. The produc-
tion term Bj + Sjf(t) comprises a basal transcription rate Bj,
which may be increased proportionally by the TF activity f(t).
Sj is the sensitivity of gene j to that TF. Our overall aim is to
estimate the parameters Bj, Sj, and Dj from the microarray
data [ j(ti)], and in particular the sensitivity Sj. If Sj is not sig-
nificantly greater than zero, then gene j is not regulated by the
TF, whereas if Sj is large and significantly different from zero
then the TF has a very strong effect on that gene.
The activity level f(t) of the TF (p53) is unknown. In order to
estimate the hidden variable f(t), we need to parametrize the
function f and estimate the resulting parameters. This raises
the problem that if we try to estimate the unknown parame-
t e r s  i n  E q u a t i o n  1  f o r  s i n g l e  g e n e  j ,  t h e n  w e  h a v e  m o r e
unknown parameters than we have data points. The
unknowns are the three parameters Bj, Sj, Dj, and the n + 1
values f(t0) ... f(tn), as compared to the n + 1 observed data
points  j(t0) ...  j(tn). (The term  j is the experimental
measurements of gene j, composed of xj + ε, where ε is the
measurement error.)
We observed that the equations for different genes are cou-
pled by the level f(t) of the TF. Thus if we measure m genes
simultaneously with microarra y s ,  t h e n  w e  h a v e  m ( n  +  1 )
measurements  j(ti) for j = 1 ... m and i = 0 ... n, but there are
only 3 m + n + 1 unknowns Bj, Sj, Dj for j = 1 ... m and f(t0) ...
f(tn). If the number of time points n is sufficiently large, then
m(n + 1) = 3 m + n + 1, and we are able to estimate the
unknowns using standard optimization methods. In practice
we applied the model to replicate measurements that requires
a modification to this approach (see Additional data file 1).
As the model stands, different parameter combinations could
give rise to identical solutions for xj(t). This is because both
the origin and the scaling of the unobserved TF activity are
arbitrary. Suppose that f(t) = α (t) + β for some constants α
≠ 0 and β. Then Equation 1 becomes the following:
Where  j = Bj + Sjβ and   = αSj. Because the TF is not
observed, we have no way to distinguish between the models
in Equation 1 and Equation 2. To overcome this ambiguity, we
first set Sj = 1 for one gene, in our case p21. This fixes α and
removes the ambiguity from the remaining Sj and reduces by
one the total number of parameters to be estimated. Second,
we assume that at the start of the experiment the activity level
of the TF is 0. In other words, we set f(t0) = 0, which is suffi-
cient to fix β and hence remove the ambiguity from the Bj. It
further reduces the parameter count by one.
Setting f(t0) = 0 has the effect of defining the basal transcrip-
tion rate Bj for each gene as the rate at the start of the experi-
ment. We assume that the p53 network is in equilibrium
before irradiation, and hence Bj can be thought of as the
equilibrium transcription rate. Similarly, f can be interpreted
as the deviation from equilibrium of the transcription factor
activity.
Discretizing the model
In a systems biology context it is necessary to screen thou-
sands of potential targets. We therefore developed a very
rapid numerical method for estimating parameters in Equa-
tion 1.
Since Equation 1 is linear, it is possible to obtain an analytic
solution:
We found that parameter estimation by direct application of
standard numerical schemes for the evaluation of integrals
was too slow. These approaches also suffer from the require-
ment to define an appropriate functional form and parametri-
zation of f(t).
Instead, motivated by collocation based approaches to
boundary value problems for nonlinear differential equa-
tions, we chose to discretize the model directly, converting the
problem into an algebraic one. We illustrate this approach
using the simplest possible discretization scheme.
To estimate the parameters in Equation 1 we must evaluate
the derivative, which we denote ∆i, on the left hand side at a
specific time point ti. Knowing the values xj(ti-1), xj(ti), and
xj(ti+1) at neighboring points, we computed the slope of xj(t)
between ti-1 and ti, and the slope between ti and ti+1. We then
dx t
dt
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combined these two values using an appropriate weighting
and obtained an estimate for ∆i (for notational convenience
we define xi = xj(ti-1)). If the time intervals are regular, so that
ti - ti-1 = ti+1 - ti, then:
This is equivalent to fitting a quadratic polynomial to the
three points, and then evaluating its derivative at ti. Higher
order approximations can be obtained by using more points
and fitting an appropriate polynomial. A suitable way of doing
this is Lagrange interpolation [42]. This gives an explicit
formula for a degree q - 1 polynomial P(t) passing through the
q points (tp, xp) ... (ti, xi) ... (tr, xr), where r = p + q - 1:
Where
We call such an approximation a q-point approximation (so
that the example above gives a three-point approximation).
An approximation of the required derivative ∆i can now be
obtained by differentiating P(t) at ti.
The right hand side is a linear function of x0 ... xn. We shall
denote the coefficients of this by Aik, so that:
Where we set Aik = 0 for k < p or k > r. (For a detailed calcula-
tion of Aik, see Additional data file 1.) We can then collate
these various coefficients into a (n + 1) × (n + 1) matrix A. If
we define the (n + 1) vectors as follows:
xj = [xj(t0) ... xj(tn)] = (x0 ... xn)
f = [f(t0) ... f(tn)] = (f0 ... fn)
1 = (1 ... 1)
Then our approximation of Equation 1 can then be written as
follows:
Axj = Bj1 + Sjf - Djxj   (6)
The formal solution is given by
xj = (A + DjI)-1(Bj1 + Sjf)
Where I is the (n + 1) × (n + 1) identity matrix. In practice we
solve Equation 6 using the Loewr-Upper decomposition [42]
of (A + DjI).
Our approach to the solution of Equation 1 is several orders of
magnitude faster than a naïve approach to solving the differ-
ential equation using an explicit fourth order Runge-Kutta,
with the typical step size that would be employed in such a
case. It also has the advantage that it is not necessary to spec-
ify a functional form for f(t). In our case f(t) is simply repre-
sented by the discrete set of values (f0 ... fn), that is by the
vector f.
Although our approach implicitly integrates the differential
equation using large step sizes (effectively ti+1 - ti), the una-
voidable errors associated with estimating f(t) swamp any
advantage gained by using smaller steps, and consequently
there is no loss of accuracy in replacing Equation 1 by Equa-
tion 6. We validated this conclusion by generating artificial
data and adding Gaussian noise of similar amplitude to that
generally seen in microarray data. We found that the error in
the parameter estimation induced by this noise overshadows
the discretization error.
Model fitting
We employed the discretized model described in Equation 6
in two different ways. First, to estimate the TF profile f(t), we
fit a microarray time series to a training set of five genes
known to depend on p53 (DDB2, p21WAF1/CIP1, SESN1/hPA26,
BIK, and TNFRSF10b/TRAILreceptor 2). In order to do this,
we also needed to estimate the parameters Bj, Sj, and Dj for
these genes, although the estimated values are of no direct
interest. We call the estimated profile obtained from this
phase   = ( 0 ...  n). We then used the estimated profile 
and applied the model to the transcription time series [ j(t0)
...  j(tn)] for each gene j in our data set to estimate Bj, Sj, and
Dj.
In each phase we employed a standard approach to fitting the
unknown parameters. We define a candidate parameter vec-
tor, which in the first phase is given by the following equation:
µ = (B1 ... Bm, S1 ... Sm, D1 ... Dm, f0 ... fn)
In the second phase it is given by:
µj = (Bj, Sj, Dj)
Equation 6 was solved for this set of parameters using the LU
decomposition of (A + DjI). In the first phase f = (f0 ... fn), with
the fi taken from the candidate parameter vector µ. In the
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second phase we used   = ( 1 ...  m) obtained from the first
phase. We then computed the error Mj (depending on µ or µj,
respectively) for each gene between the model solution and
the actual data:
We assume the measurement errors to be independent and
normally distributed with standard deviation σj(ti) for the
observation at time ti of gene j. The calculation of σj(ti) is
detailed in Additional data file 1.
In the first phase the error over the training set (containing m
genes) is then
To fit the model, we then varied µ or µj in a systematic way to
find the parameters that make M or Mj as small as possible
using a MCMC method [23]. This has the added advantage of
also providing confidence intervals for the resulting parame-
ter estimates. We assume that the measurement errors are
Gaussian, giving a likelihood function proportional to exp (-
M/2) or exp(-Mj/2). A Metropolis-Gibbs sampler was then
applied with this likelihood. Because neither Bj nor Dj can
take negative values, the MCMC sampling was carried out in
logarithmic space for these two parameters [(og(Bj) and
log(Dj), respectively).
To improve the convergence speed of the MCMC scheme it is
advantageous to make jumps in the parameter space that are
commensurate with the different parameter scales. This is
particularly the case in the first phase, in which the dimen-
sionality of the parameter space is high. We estimated such
scales by running partial MCMC schemes on each group of
parameters in turn, before running the full MCMC scheme.
Specifically, parameters were grouped into four sets: degra-
dation, transcription, basal rates, and TF profile. For each set
a scale was determined to achieve an acceptance rate of
approximately 25%. A final tuning run was carried out on the
whole parameter set in order to achieve the prescribed
acceptance rate of 25%. The main MCMC was seeded with the
minimum of M found from a standard optimization proce-
dure (the Nelder-Mead simplex algorithm). A burn in of
10,000 iterations was applied before proper sampling. The
final sample of 10,000 observations was extracted at random
from the 107 iterations following burn in. We verified that
these choices yielded good convergence.
In the second phase, in which the TF profile is known and
there are only three parameters to determine, a long iteration
run is unnecessary. We found that 105 iterations were suffi-
cient to produce good convergence. Once again 10,000 obser-
vations randomly sampled from those iterations were used to
compute the relevant statistics.
Additional data files
The following additional data are included with the online
version of this article: A Word document giving details of the
rescaling of array data, derivation of the coefficients of the
differential operator, extension of model fitting to replicate
measurements, and estimation of the measurement error
(Additional data file 1).
Additional data file 1 A Word document giving details of the rescaling of array data A Word document giving details of the rescaling of array data, der- ivation of the coefficients of the differential operator, extension of  model fitting to replicate measurements, and estimation of the  measurement error Click here for file
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